News
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving medicines that it later cleared.
The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to drugmakers, a significant move to increase transparency of the agency's work.
Used for diagnosing gastroesophageal reflux, the devices may not attach or detach correctly, potentially causing serious ...
1don MSN
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
The US Food and Drug Administration has started making rejection letters that pharmaceutical companies traditionally keep ...
A growing disconnect remains between what generics are approved and what are actually accessible, GoodRx said.
FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...
Investors have long asked the FDA to share its reasons for rejecting drugs, arguing that companies can use the agency’s silence on the matter to mislead the market.
Weaver Nut Company, Inc. announced a recall for specific lots of its semi-sweet chocolate nonpareils on June 17 due to the undeclared presence of milk.
Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results